Process / pipelineClinical / epidemiology
Cox Proportional Hazards — Regression Model for Time-to-Event Data
The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI: 10.1111/j.2517-6161.1972.tb00899.x ↗
- Collett, D. (2015). Modelling Survival Data in Medical Research (3rd ed.). CRC Press. ISBN: 978-1439856789
Related methods
Referenced by
Adaptive Cox Proportional HazardsAdaptive Survival AnalysisBayesian Competing Risks AnalysisBayesian Cox Proportional HazardsBayesian Kaplan-Meier analysisFine-Gray Competing Risks ModelKaplan-Meier AnalysisKaplan-Meier EstimatorMatched Competing Risks AnalysisMatched Cox Proportional HazardsMatched Kaplan-Meier AnalysisMatched Survival AnalysisMeta-analytic competing risks analysisMeta-analytic Cox proportional hazardsMeta-analytic Kaplan-Meier analysisMeta-analytic survival analysisMulticenter Competing Risks AnalysisMulticenter Cox proportional hazardsMulticenter Kaplan-Meier analysisNested case-controlPragmatic Kaplan-Meier analysisPragmatic survival analysisProspective Competing Risks AnalysisProspective Cox proportional hazardsProspective Dose-Response AnalysisProspective Survival AnalysisRetrospective competing risks analysisRetrospective Cox proportional hazardsRetrospective Kaplan-Meier AnalysisRetrospective survival analysisRisk-adjusted competing risks analysisRisk-adjusted Cox Proportional HazardsRisk-adjusted dose-response analysisRisk-adjusted Kaplan-Meier analysisRisk-adjusted Nested Case-ControlRisk-adjusted Phase III clinical trialRisk-adjusted survival analysisSurvival Analysis Power Analysis